Revolutionary Allergy Treatment Hits Japan

In a groundbreaking move, Japan has approved **neffy®**, the world’s first needle-free epinephrine nasal spray, designed to rescue individuals during emergency allergic reactions, including life-threatening anaphylaxis. Now available in both 1 mg and 2 mg doses, this innovative treatment is aimed at both adults and children over 15 kg.

A New Era for Allergy Management in Japan

With approximately **900,000 people** in Japan suffering from food allergies, and a staggering rise in cases among children, the need for accessible emergency treatments has never been more critical. Despite the alarming statistics, a recent survey revealed that only **14% of patients** diagnosed with anaphylaxis had access to an epinephrine auto-injector, and even fewer used it effectively at critical moments.

Meet neffy: Your New Allergy Lifesaver!

Developed by ARS Pharmaceuticals and marketed by Alfresa Holdings, neffy is designed to fill the gaps left by traditional injectable options. As CEO Richard Lowenthal explained, "This represents a significant breakthrough… empowering patients and caregivers to quickly respond to severe allergic reactions without the hassle of needles." **neffy** is compact, easy to carry, and boasts an impressive 24-month shelf life compared to other forms of epinephrine.

What Makes neffy a Game-Changer?

Unlike conventional auto-injectors, neffy eliminates the fear of needles and simplifies administration during emergencies when every second counts. With this nasal spray, patients can administer the life-saving medication as soon as symptoms arise, potentially averting dire outcomes.

Availability and Future Prospects

Expected to hit the shelves by **Q4 2025**, neffy’s approval in Japan is just the beginning. It is already commercially available in the U.S. and has plans for launches across Europe, Canada, Australia, New Zealand, and China by 2026, signifying a growing recognition of the urgent need for user-friendly allergy treatments worldwide.

Conclusion: A Bright Future for Allergy Sufferers

With neffy paving the way, it's a monumental step towards enabling allergy sufferers to lead safer, more confident lives. As we await its launch, the hope is that this needle-free innovation will significantly reduce the number of missed opportunities for timely treatment of allergic emergencies.